Although the study was not powered for efficacy end points, a tendency for a reduction in brain amyloid at the two highest doses and a positive trend on cognition and function were also observed.
← all excerpts
Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease.
1
—
—